BIOMARIN PHARMACEUTICAL INC
BMRNNASDAQ🏆 #639 by market capEarnings Oct 26US Equity
$69.55▲ $0.67 (+0.97%)
Market closed · at close1h—
24h▲ 1.0%
7d—
14d—
30d—
1y—
🏦Market Cap
$13.44B
Mid Cap
📈Revenue Growth (YoY)
+11.2%
Healthy
📊Gross Margin
79.6%
High
💵FCF Margin
21.3%
Strong
⚖️P/S Ratio
3.9x
Fair
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
1.20
Expected
0.95
beat
+26.70%
YoY −16.70%
Revenue
Actual
$989.71M
Expected
$932.03M
beat
+6.20%
YoY +19.90%
Consensus estimates
Recent quarters
Q3 2026
1.20
beat
Q2 2026
0.76
miss
Q1 2026
-0.24
miss
Q4 2025
0.12
beat